Clinical trial

Non-Specific Effects of Standard Titre Measles Vaccination

NCT00168662 · Bandim Health Project, Other · Completed

Key facts

NCT number NCT00168662
Title Non-Specific Effects of Standard Titre Measles Vaccination
Official title Trial of Two-Dose Standard Measles Vaccination Schedule: Long-Term Impact on Morbidity and Mortality of a Two-Dose Vaccination Schedule at 6 and 9 Months of Age Compared With a Standard Regimen of One Dose at 9 Months of Age
Lead sponsor Bandim Health Project, Other
Collaborators International Cooperation with Developing Countries Danish Council for Development Research Medical Research Council Unit, The Gambia
Status Completed
Phase Phase 4
Study type Interventional
Conditions Measles
Intervention type Biological
Interventions Measles and inactivated polio vaccine
Enrollment 7,800
Start date Mar 1, 1995
Primary completion Jan 1, 2006
Completion Jan 1, 2006
First posted Sep 15, 2005
Last update posted Feb 26, 2008
Countries Guinea-Bissau

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies